130 related articles for article (PubMed ID: 33867228)
41. 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation.
Petrolati A; Festi D; De Berardinis G; Colaiocco-Ferrante L; Di Paolo D; Tisone G; Angelico M
Aliment Pharmacol Ther; 2003 Oct; 18(8):785-90. PubMed ID: 14535871
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of the 13C-octanoate breath test as a surrogate marker of liver damage in animal models.
Shalev T; Aeed H; Sorin V; Shahmurov M; Didkovsky E; Ilan Y; Avni Y; Shirin H
Dig Dis Sci; 2010 Jun; 55(6):1589-98. PubMed ID: 19731033
[TBL] [Abstract][Full Text] [Related]
43. Corrigendum to 'Adiponectin involved in portal flow hepatic extraction of 13C-methacetin in obesity and non-alcoholic fatty liver.' [European Journal of Internal Medicine 89C (2021) 56-64].
Di Ciaula A; Carbone F; Shanmugham H; Molina-Molina E; Bonfrate L; Ministrini S; Montecucco F; Portincasa P
Eur J Intern Med; 2022 Apr; 98():135. PubMed ID: 35177305
[No Abstract] [Full Text] [Related]
44. UCP1 -3826 AG+GG genotypes, adiponectin, and leptin/adiponectin ratio in severe obesity.
Labruna G; Pasanisi F; Nardelli C; Tarantino G; Vitale DF; Bracale R; Finelli C; Genua MP; Contaldo F; Sacchetti L
J Endocrinol Invest; 2009 Jun; 32(6):525-9. PubMed ID: 19474520
[TBL] [Abstract][Full Text] [Related]
45. Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial.
Naeini F; Namkhah Z; Tutunchi H; Rezayat SM; Mansouri S; Jazayeri-Tehrani SA; Yaseri M; Hosseinzadeh-Attar MJ
Trials; 2021 Nov; 22(1):801. PubMed ID: 34774104
[TBL] [Abstract][Full Text] [Related]
46. Nuclear medicine liver function tests for pregnant women and children. 1. Breath tests with 14C-methacetin and 13C-methacetin.
Krumbiegel P; Günther K; Faust H; Möbius G; Hirschberg K; Schneider G
Eur J Nucl Med; 1985; 10(3-4):129-33. PubMed ID: 3996441
[TBL] [Abstract][Full Text] [Related]
47. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
[TBL] [Abstract][Full Text] [Related]
48. Usefulness of 13C-methacetin breath test in liver function testing in Amanita phalloides poisoning; breast feeding woman case.
Hydzik P; Bielañski W; Ponka M; Wójcicki M; Lubikowski J; Pach J; Pawlik W
Clin Toxicol (Phila); 2008 Dec; 46(10):1077-82. PubMed ID: 18821093
[TBL] [Abstract][Full Text] [Related]
49. Fructose as a key player in the development of fatty liver disease.
Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
[TBL] [Abstract][Full Text] [Related]
50. Improved hepatic lipid composition following short-term exercise in nonalcoholic fatty liver disease.
Haus JM; Solomon TP; Kelly KR; Fealy CE; Kullman EL; Scelsi AR; Lu L; Pagadala MR; McCullough AJ; Flask CA; Kirwan JP
J Clin Endocrinol Metab; 2013 Jul; 98(7):E1181-8. PubMed ID: 23616151
[TBL] [Abstract][Full Text] [Related]
51. Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models.
Ahmad A; Ali T; Kim MW; Khan A; Jo MH; Rehman SU; Khan MS; Abid NB; Khan M; Ullah R; Jo MG; Kim MO
Metabolism; 2019 Jan; 90():31-43. PubMed ID: 30473057
[TBL] [Abstract][Full Text] [Related]
52. Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects.
Iacobellis G; Barbarini G; Letizia C; Barbaro G
Obesity (Silver Spring); 2014 Feb; 22(2):332-6. PubMed ID: 24115757
[TBL] [Abstract][Full Text] [Related]
53. Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis.
Bechmann LP; Kocabayoglu P; Sowa JP; Sydor S; Best J; Schlattjan M; Beilfuss A; Schmitt J; Hannivoort RA; Kilicarslan A; Rust C; Berr F; Tschopp O; Gerken G; Friedman SL; Geier A; Canbay A
Hepatology; 2013 Apr; 57(4):1394-406. PubMed ID: 23299969
[TBL] [Abstract][Full Text] [Related]
54. Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents.
de Piano A; de Mello MT; Sanches Pde L; da Silva PL; Campos RM; Carnier J; Corgosinho F; Foschini D; Masquio DL; Tock L; Oyama LM; do Nascimento CM; Tufik S; Dâmaso AR
Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1313-24. PubMed ID: 22932160
[TBL] [Abstract][Full Text] [Related]
55. Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity.
Barchetta I; Enhörning S; Cimini FA; Capoccia D; Chiappetta C; Di Cristofano C; Silecchia G; Leonetti F; Melander O; Cavallo MG
BMC Med; 2019 Apr; 17(1):85. PubMed ID: 31035998
[TBL] [Abstract][Full Text] [Related]
56. Comparison of two dosage regimens of the substrate for the [13C]methacetin breath test.
Kasicka-Jonderko A; Jonderko K; Budniok M; Krusiec-Świdergo B; Błońska-Fajfrowska B
Isotopes Environ Health Stud; 2013; 49(1):109-21. PubMed ID: 22827182
[TBL] [Abstract][Full Text] [Related]
57. Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis.
Handa P; Maliken BD; Nelson JE; Morgan-Stevenson V; Messner DJ; Dhillon BK; Klintworth HM; Beauchamp M; Yeh MM; Elfers CT; Roth CL; Kowdley KV
Hepatology; 2014 Jul; 60(1):133-45. PubMed ID: 24464605
[TBL] [Abstract][Full Text] [Related]
58. [Study of reactive oxygen species and adiponectin for chronic HBV infection combined with nonalcoholic fatty liver diseases].
Xu L; Zhong Y; Su ST; Liu YG; Lyu FN; Zhou XL; Ren JQ; Li P; Shi RF; Jiang Y; Fan JG; Mi YQ
Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):247-253. PubMed ID: 32306658
[No Abstract] [Full Text] [Related]
59. 13C-methacetin and 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis.
Holtmeier J; Leuschner M; Schneider A; Leuschner U; Caspary WF; Braden B
Scand J Gastroenterol; 2006 Nov; 41(11):1336-41. PubMed ID: 17060128
[TBL] [Abstract][Full Text] [Related]
60. Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals.
Saponaro C; Sabatini S; Gaggini M; Carli F; Rosso C; Positano V; Armandi A; Caviglia GP; Faletti R; Bugianesi E; Gastaldelli A
Liver Int; 2022 Nov; 42(11):2418-2427. PubMed ID: 35900229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
